149. Obstructive sleep apnea (OSA) is defined as: a. An apnea-hypopnea index (AHI) of 5 or greater, with associated symptoms, or an AHI of 15 or greater, regardless of symptoms. b. An overall nighttime oxygen saturation index (OSI) of 4% or greater, with associated symptom, or an OSI of 12% or greater, regardless of symptoms. c. An AHI greater than 30, regardless of symptoms. d. The presence of at least three main symptoms of OSA. 150. The estimated percentage of adults 30 to 70 years of age who currently have moderate to severe sleep apnea is: a. 6% of men and 2% of women. b. 9% of men and 7% of women. c. 13% of men and 6% of women. d. 19% of men and 9% of women. 151. In both males and females, the strongest risk factor for OSA is: a. Obesity. b. Excessive tobacco and alcohol use. c. A family history of OSA. d. Stress. 152. Longitudinal and cross-sectional studies have shown a strong association between OSA or hypopnea and: a. Hypertension. b. Gastroesophageal reflux disease. c. Parkinson’s disease. d. Type 1 diabetes mellitus. 153. OSA appears to be an independent risk factor for which of the following diseases? c. Type 1 diabetes mellitus. d. Type 2 diabetes mellitus. 154. The incidence of depression per 1,000 person was 18% compared to 8% of individuals without OSA: a. Hypothyroidism. b. Hyperthyroidism. 155. The American Association of Sleep Medicine guidelines stress that the diagnosis of OSA starts with a sleep history that can be obtained as part of: a. A routine health maintenance evaluation. b. Specialized sleep testing. c. A recall exam with the dentist. d. A visit with a sleep specialist. 156. What is a common orofacial characteristic of a patient with OSA? a. A reduced, compressed, or shortened uvula. b. Gingival inflammatory changes in the mandibular anteriors. c. An enlarged tongue with scalloped borders. d. Moderate to severe dental attrition. 157. Which of the following is a radiographic sign of OSA? a. A low palatal vault. b. Posterior displacement of the symphysis. c. Decreased lateral wall thickness and fat pad size. d. Decreased distance between the mandibular plane and hyoid bone. 158. The most reliable indicator of OSA is: a. Gastric reflux. b. Reduced memory. c. Gasping or choking during sleep. d. Heavy, muffled snoring upon falling asleep. a. One month after an OSA diagnosis. b. Six months after an OSA diagnosis. c. Nine months after an OSA diagnosis. d. One year after an OSA diagnosis.
159. Which of the following are major symptoms of OSA? a. Loss of appetite and nausea. b. Dizziness and vertigo. c. Sudden weight gain with an associated increase in cholesterol levels. d. Excessive daytime sleepiness and impaired cognitive functioning. 160. Which test is considered the gold standard in diagnosing OSA? a. A polysomnogram (PSG) conducted in a sleep laboratory. b. An electroencephalogram (ECG) conducted in the physician’s office. c. A sleep study conducted at home using a portable sleep monitor. d. The patient’s performance on key cognitive tasks. e. 161. The primary treatment modality for adults with OSA is: a. Continuous positive airway pressure (CPAP). b. Oral appliance (OA) therapy. c. Behavior modification for weight loss and sleeping strategies. d. Surgical modification of the upper airway. 162. The most commonly used OAs for treating OSA are: 163. Candidates for an OA require which of the following? a. A diagnosed temporomandibular joint disorder (TMD). b. At least first molar occlusion bilaterally, in both arches. c. The ability to protrude the mandible. d. Recent weight loss of 40 pounds or more. 164. Once an OA is fitted optimally and efficacy is established, follow-up office visits with the dental professional should occur: a. Every 6 weeks for the life of the device. b. Every 3 months for the first year and at least every 6 months thereafter. c. Every 6 months for the first year and at least annually thereafter. d. At the sole discretion of the patient’s general dentist. 165. Schwartz and colleagues’ 2017 meta-analysis comparing a. Maxillary advancement devices (MaxADs). b. Maxillary protrusion devices (MaxPDs). c. Mandibular advancement devices (MADs). d. Mandibular protrusion devices (MPDs). the results of CPAP treatment versus MAD found: a. A statistically significant difference in the post- treatment quality of life or mental health of CPAP users. b. That MAD users had a statistically significant improvement in excessive daytime sleepiness. c. A significantly greater improvement in the post- treatment AHI in favor of CPAP therapy. d. That compliance with using CPAP therapy was greater than with MAD. 166. Which patients are most likely to be good candidates for sleep apnea surgery? a. Patients with mild to moderate OSA. b. Patients with severe OSA. c. Patients who are in better overall health than the average OSA patient. d. Patients with discrete anatomic irregularities that are amenable to surgery.
Course Code: DFL02AP
Page 118
Book Code: DHFL2624
EliteLearning.com/ Dental
Powered by FlippingBook